Clinical Trial Update: Montelukast in Parkinson Disease [Phase 2, Phase 3]

View source ↗

Summary

Montelukast is being evaluated in Phase 2 and Phase 3 trials for Parkinson disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Mostafa Bahaa | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: RECRUITING